SPIE Photonics West 2025 Now Open for Registration
Registration has opened for SPIE Photonics West 2025, which will run from 25 to 30 January at San Francisco’s Moscone Center. The largest annual conference and exhibition in optics and photonics, Photonics West brings together researchers, innovators, engineers, and business leaders from across the globe for an exciting week of research-sharing, collaboration opportunities, and innovation-inspiring exchanges. This year, the week will include 4,500-plus technical presentations across more than 100 technical conferences, as well as hosting over 1,200 companies in four focused exhibitions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241022216957/en/
SPIE Photonics West welcomes the optics and photonics community to San Francisco's Moscone Center. (Photo: Business Wire)
SPIE Photonics West has four major application areas showcasing the latest technologies and discoveries that utilize optics and photonics. BiOS highlights new research in biophotonics, biomedical optics, and imaging for diagnostics and therapeutics; LASE focuses on the laser industry and its diverse applications; OPTO covers optoelectronics, photonic materials, and optical devices; and Quantum West features quantum 2.0 technologies from quantum sensing and information systems to quantum-enabled materials, devices, and biology.
The four exhibitions during Photonics West feature more than 1,200 companies, with industry-focused presentations, product launches, live demonstrations, and cutting-edge technologies representing the diverse and healthy photonics industry.
The BiOS Expo, featuring new and transformative technologies in biomedical optics and healthcare applications, runs 25-26 January. Also open to Photonics West attendees, the AR | VR | MR Exhibition — with a focus on headsets and hardware for XR applications — takes place on 28-29 January. The Quantum West Expo, 28-29 January, will showcase international providers of the latest quantum-enabled and -enabling technologies. And the Photonics West Exhibition, running 28-30 January, encompasses the latest from laser manufacturers and suppliers as well as other innovative optics and photonics devices, components, systems, and services. In addition, the dynamic SPIE industry program offers an informative focus on the markets and applications shaping the photonics industry. A free registration provides access to all four exhibitions and the industry program.
Complementing the wide-ranging SPIE industry program are the Quantum West Business Summit, addressing the latest efforts that are moving quantum technologies to market; the popular Prism Awards gala evening which honors the best industry innovations; and the fast-paced SPIE Startup Challenge, which showcases exciting, emerging companies.
“We’re very excited to welcome the returning and new companies to our exhibitions during the week of Photonics West,” said SPIE Global Exhibition Services Director Bonnie Peterson. “Every year, I'm amazed by the innovations on display, as well as the creativity and ingenuity that our exhibitors bring to their booths and presence on the floor. I know that while we're hard at work putting together four distinct exhibitions – BiOS Expo, AR | VR | MR, Quantum West Expo, and Photonics West – they are working hard to ensure every Photonics West attendee will leave the show with new ideas and product solutions.”
Dynamic Hot Topics and plenary speakers will highlight the latest innovative research breakthroughs, with two Nobel laureates, Moungi Bawendi, Massachusetts Institute of Technology, and Eric Cornell, University of Colorado Boulder, presenting. Fellow plenary speakers include Daniel Elson, Imperial College London; Michalina Gora, Wyss Center for Bio and Neuroengineering; Benjamin Miller, University of Rochester Medical Center; Vivek J. Srinivasan, New York University Grossman School of Medicine; Kate Grieve, Institut de la Vision/INSERM (National Institute of Health and Medical Research, France); Frédéric Leblond, Polytechnic Montréal; Seemantini Nadkarni, Wellman Center for Photomedicine and Harvard Medical School; Paras N. Prasad, University at Buffalo; Naomi J. Halas, Rice University; Joanna Depciuch, Institute of Nuclear Physics, Polish Academy of Sciences; Constantin Häfner, Fraunhofer Institute for Laser Technology; Aiko Narazaki, National Institute of Advanced Industrial Science and Technology, Japan; Nathalie Picqué, Max Born Institute; Henry Helvajian, The Aerospace Corporation; Paul Corkum, University of Ottawa; Alexander Szameit, University of Rostock; Christine Silberhorn, Paderborn University; Tara Fortier, National Institute of Standards and Technology; and Andrew Forbes, University of the Witwatersrand.
Alongside the conferences and exhibitions, Photonics West will also offer 57 technical courses, including six new courses on topics such as designing experiments in optics and photonics, practical applications of the Monte Carlo method in biomedical optics, petawatt lasers, and cleaning basics for optical components and hardware. The wide-ranging educational program complements numerous professional development workshops, a comprehensive job fair, and valuable networking opportunities for technical attendees, SPIE Members, and exhibitors.
Full conference registration for Photonics West also includes access to the co-located three-day SPIE AR | VR | MR event, which focuses on augmented, virtual, and mixed reality and the vital role that optics and photonics play in hardware and headset development. This popular program incorporates industry talks, keynotes, and panels with speakers representing a range of exciting companies alongside a two-day exhibition.
For the second year, SPIE will host its Global Business Forum on 27 January, co-located with Photonics West. This one-day event will a focus on current and emerging trends across the international optics and photonics industry and markets and will provide actionable insights for business leaders, including the release of SPIE’s annual report on the state of the optics and photonics industry. Confirmed speakers include representatives from ASML, MKS Instruments, Thorlabs, Singular Photonics, Needham & Company, Yole Group, Tematys, and Ceres Technology Advisors. Registration for the Global Business Forum is separate from Photonics West and will be available via the event website.
In addition, the week will include a special Women in Optics event on 26 January to celebrate 20 years of the SPIE Women in Optics planner and notebook. The one-day gathering will feature panels and presentations from optics and photonics luminaries who have all been highlighted in the notebook, from ETH Zurich’s Ursula Keller to Johns Hopkins University’s Muyinatu Bell, Edmund Optics’ Marisa Edmund, and ZEISS Group’s Ulrike Boehm. Registration for the Women in Optics celebration is separate from Photonics West and will be available via the event website.
“Photonics West 2025 is shaping up to be an exciting and inspiring week,” said SPIE Senior Director of Technical Programs Marilyn Gorsuch. “As always, it marks the first major community gathering of the year, bringing together a vibrant mix of industry leaders, engineers, and researchers. With its myriad opportunities for discussion, knowledge-sharing, and networking, Photonics West is the place for the global optics and photonics community to kick off a stellar year of innovation and collaboration, and we look forward to hosting you in San Francisco in January.”
For more information and to register, please visit https://spie.org/pw.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $24 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241022216957/en/
Contacts
Daneet Steffens
Public Relations Manager
daneets@spie.org
+1 360 685 5478
@SPIEtweets -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2F
spietweets&esheet=54140571&newsitemid=20241022216957&lan=en-US&anchor=%40SPIEtwe
ets&index=20&md5=e2200765cfd39523cf691561e3ac4394
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom